Wednesday, May 19, 2010

Health Press Release – Newsletter for May 19, 2010

Wednesday, May 19, 2010


TAIJI Announces Official Operation of Its Sintering FGD Project for Tangshan

NINGBO, China, May 18, 2010 – Ningbo Taiji Environmental Protection Equipment Co., Ltd. (TAIJI)'s FGD
(Flue-gas desulfurization) technology was officially put into operation,
successfully being used in 230 m2 sintering. For the project, TAIJI chose to
use steel slag as an absorbent instead of lime or other absorbents
traditionally used in desulfurization. In comparison to the use of [...]

Gold Standard/Elsevier Offers Timely, Transparent, Reliable Drug Pricing Data, Including Average Wholesale Price (AWP)

Amidst Industry Unrest due to Drug Pricing Benchmark Upheaval, Gold Standard/Elsevier to Continue Publishing AWP and Other Pricing Standards

TAMPA, Florida, May 18, 2010 – Gold Standard/Elsevier, publisher of drug information databases and
decision support solutions, has announced its commitment to continue
publishing transparent drug pricing information, including average wholesale
price (AWP) and all other current and future [...]

Frost & Sullivan Web Conference on the European Melanoma Skin Cancer Market: Will the Drugs in Pipeline Deliver?

LONDON, May 18, 2010 – There are only two FDA/EMEA approved drugs currently available for
treating advanced melanoma. The available drugs, however, are not completely
effective and have adverse effects. Unmet needs of patients, especially those
with advanced melanoma are therefore quite high and have led to a low drug
adoption and market growth over the years. The [...]

IDEV Technologies Announces European Launch of SUPERA VERITAS(TM) Stent Delivery System

Innovative Technology Provides Precision, Ease of Use For Delivery of SUPERA(R) Stent

WEBSTER, Texas, May 18, 2010 – IDEV Technologies, Incorporated, (IDEV) an emerging leader in the
development and marketing of minimally invasive medical technologies, today
announced the European launch of the SUPERA VERITAS(TM) Peripheral Vascular
System, a novel and innovative stent delivery system designed to be reliable,
easy [...]

Simbionix ANGIO Mentor Plays Important Role in Physician Training and Certification

CLEVELAND, Ohio, May 18, 2010 – Simbionix USA Corporation, the world's leading provider of medical
education and simulation training products for medical professionals and the
healthcare industry, is proud to report that their ANGIO Mentor virtual
reality simulator was used during the 4th International Congress of the
Polish Vascular Societies in April 2010 for the training and certification [...]

Accuray Hires General Manager for the EIMEA Region

SUNNYVALE, California, May 18, 2010 – Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of
radiosurgery, announced today that Vittorio Puppo, M.D., has joined Accuray
as General Manager of the EIMEA (Europe India Middle East and Africa) region,
effective May 17, 2010.

Prior to joining Accuray, Puppo worked for Covidien, a healthcare [...]

Chiltern Announces New Offices and Expansion Plans in Asia Pacific

LONDON, May 18, 2010 – Chiltern International Limited (Chiltern), a global contract research
organization (CRO) has announced its expansion plans in Asia Pacific.

Chiltern has established two new offices and launched operations in
Australia and Singapore – with Singapore acting as the hub for its operations
in Southeast Asia. This builds further upon Chiltern's [...]

Breathe Technologies Secures US$23 Million in Series C Financing

John Miclot elected chairman; FDA clearance received.
SAN RAMON, California, May 18, 2010 – Breathe Technologies, Inc., a manufacturer of innovative technology
solutions for people with respiratory conditions, including chronic
obstructive pulmonary disease and sleep apnea, announced today it has secured
US$23 million in Series C financing. The financing was led by DAG Ventures
and included Kleiner Perkins Caufield [...]

Oncolytics Biotech(R) Inc. Announces Publication of Phase I Clinical Trial Results in Clinical Cancer Research

CALGARY, Canada, May 18, 2010 – Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced
today that a paper entitled "Two-Stage Phase I Dose-Escalation Study of
Intratumoural Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients
with Advanced Cancers," has been published in the online version of the
journal Clinical Cancer Research.

The paper covers final results [...]

Copyright© 2010 Gaea Times